US 7306914
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
granted A61PA61P43/00
Quick answer
US patent 7306914 (Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy) held by Odyssey Thera Inc. expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Odyssey Thera Inc.
- Grant date
- Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P43/00